Description
Developer of a biotechnology platform intended to synthesize DNA molecules. The company's platform uses lyophilized for DNA replication and usually works in pairs to create two identical DNA strands from a single original DNA molecule, enabling doctors to perform DNA testing in the field of DNA.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Bankruptcy: Liquidation | 01-Feb-2013 | Completed | Bankruptcy: Liquidation | |||
1. Early Stage VC | 19-Jun-2007 | Completed | Generating Revenue |